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Abstract: Peroxisomal disorders encompass a variety of pathologies with different clinical manifestations. X-linked 
adrenoleukodystrophy, an inherited neurodegenerative pathology, is characterized by mutation of a peroxisomal transport 
protein involved in the catabolism of very long-chain fatty acids (VLCFAs). These particular fatty acids abnormally accu-
mulate in plasma and in all tissues due to the enhancement of fatty acid elongation and the impairment of fatty acid catabol-
ism which takes place initially in the peroxisomes and afterward in the mitochondria. VLCFA accumulation cannot explain 
the molecular mechanisms underlying clinical manifestations in patients. Peroxisomal pathways include a product that is 
considered lost, but that could have a role in peroxisomal disorders: the heat produced during VLCFA catabolism. VLCFA 
accumulation is due to peroxisomal beta-oxidation impairment and to the enhancement of fatty acid elongation. The heat 
produced during peroxisomal metabolism could be a crucial factor related to the molecular mechanisms altered in X-linked 
adrenoleukodystrophy. VLCFA accumulation could be strongly related to the impairment of heat production, which is lost 
in X-linked adrenoleukodystrophy, a sort of energy necessary for the cell metabolism, which could contribute to the sec-
ondary clinical manifestations of peroxisomal disorders. Heat is not only produced during peroxisomal catabolism but also 
in countless metabolic pathways. It is a form of energy that could influence several parameters and could be involved in 
peroxisomal and metabolic disorders in general. 
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1. Introduction 
Although many metabolic disorders, have been exten-
sively studied, we receive the impression that something 
escapes our comprehension, something very general that is 
difficult to grasp. The molecular mechanisms underlying 
this hypothesis could be very general. For this reason, we 
will focus on peroxisomal molecular mechanisms and their 
possible relationship with peroxisomal pathologies. 
Peroxisomal disorders encompass a variety of patholo-
gies with different clinical manifestations. X-linked adreno-
leukodystrophy (X-ALD) is a peroxisomal, neurodegenera-
tive disorder, that is characterized by different phenotypes. 
The mutated gene ABCD1 encodes for the half-size trans-
porter protein (ALDP), found in peroxisomes, involved in 
the transport and subsequent shortening of very long-chain 
fatty acids (VLCFAs), a process also named beta-oxidation 
[1-3]. In childhood cerebral X-ALD, a severe inflammatory 
phenotype, the abnormal accumulation of VLCFAs induces 
the activation of lipoxidative enzymes and inflammatory 
mediators, leading to neuroinflammatory demyelination [4]. 
Metabolic alterations, associated with oxidative stress, con-
tribute to the development of neurodegenerative processes 
[5]. 
VLCFAs are initially beta-oxidized by the peroxisomes 
and are further catabolized by the mitochondria, various 
metabolites are produced to be utilized by other metabolic 
pathways (e.g. ATP, a source of energy). 
In X-ALD, peroxisomal VLCFA beta-oxidation is re-
duced, and the elongation of short fatty acids (FAs) to 
VLCFAs is enhanced, yielding a generally abnormal accu-
mulation of these particularly long FAs in plasma and in all 
tissues of affected patients. VLCFA plasma levels are the 
biomarkers of X-ALD [6,7]. 
2. Presentation of the Hypothesis 
VLCFA accumulation cannot really explain the molecu-
lar mechanisms underlying clinical manifestations in pa-
tients. In X-ALD, FA elongation is enhanced and VLCFA 
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catabolism is reduced. Another product related to VLCFA 
metabolism could be, in general, the energy coming from 
VLCFA catabolism. This shortage could contribute to the 
molecular impairment of the disease. 
Peroxisomes do not produce ATP, of the several metabol-
ic pathways and products that come from the peroxisomes, 
a particular product is the heat, which is a form of energy. 
The heat produced by these organelles is considered lost 
[8], but this cannot be true. 
3. Implication of the Hypothesis 
In the cell, heat is generated in a variety of metabolic 
pathways. Although energy reserves or temperature varia-
tions are rarely considered in biological studies , they could 
modulate  different parameters, such as  tau projection do-
main [9]. Peroxisomal heat has been considered in relation-
ship with catalase and thermoosmosis [10] but it could have 
different roles in cellular pathways.  
Considering the peroxisomal disorder X-ALD and 
VLCFA homeostasis, the heat or energy produced during 
peroxisomal VLCFA catabolism could easily diffuse out-
side the peroxisomes, either providing input to other cellu-
lar metabolisms or being a self-sustaining product modulat-
ing VLCFA homeostasis. Peroxisomal beta-oxidation could 
be a heat-dependent system.  
FA elongation is a complex pathway that takes place 
mainly in the microsomal system, and requires specific 
elongases. Elongase activity, enhanced in X-ALD, could 
require a low level of energy. In X-ALD heat could have a 
role in VLCFA homeostasis and have a link with the key 
role of acyl-CoA metabolism and with the mutated ALDP, 
which could be a heat-sensitive protein or a temperature 
stabilizer [11-15]. 
In general we need to improve our molecular knowledge 
related to heat production, and its role in cellular metabol-
ism should be reconsidered.  
In conclusion VLCFA accumulation could be strongly 
related to the impairment of heat production and could con-
tribute to the secondary clinical manifestations of the pe-
roxisomal disorder X-ALD. 
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